Ultragenyx (RARE) reported $147.03 million in revenue for the quarter ended June 2024, representing a yearover-year increase of 35.8%. EPS of -$1.52 for the same period compares to -$2.25 a year ago. The reported revenue compares to the Zacks Consensus Estimate of $123.42 million, representing a surprise of +19.13%. The company delivered an EPS surprise of +7.32%, with the consensus EPS estimate being -$1.64. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wa ...